In vitro activity of ceftobiprole against coagulase-negative staphylococci isolated in the USA

International Journal of Antimicrobial Agents

Volumn 31, Issue 3, 2008, Pages 294-296

  Srinivasan, Velusamy ^a   McGowan Jr , John E ^a   McAllister, Sigrid ^b   Tenover, Fred C ^b  

^a EMORY UNIVERSITY   (United States)

^b NATIONAL CENTER FOR EMERGING AND ZOONOTIC INFECTIOUS DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; AMPICILLIN; CEFEPIME; CEFTAZIDIME; CEFTOBIPROLE; IMIPENEM; OXACILLIN; VANCOMYCIN;

ANTIMICROBIAL ACTIVITY; BACTERIUM ISOLATE; IN VITRO STUDY; LETTER; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL; STAPHYLOCOCCUS; STAPHYLOCOCCUS CAPITIS; STAPHYLOCOCCUS HAEMOLYTICUS; STAPHYLOCOCCUS LUGDUNENSIS; STAPHYLOCOCCUS SAPROPHYTICUS; STAPHYLOCOCCUS SIMULANS; UNITED STATES;

ANTI-BACTERIAL AGENTS; CEPHALOSPORINS; COAGULASE; MICROBIAL SENSITIVITY TESTS; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS; UNITED STATES;

EID: 39149089660     PISSN: 09248579     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijantimicag.2007.10.027     Document Type: Letter

References (7)

1. Bogdanovich T., Ednie L.M., Shapiro S., and Appelbaum P.C. Antistaphylococcal activity of ceftobiprole, a new broad-spectrum cephalosporin. Antimicrob Agents Chemother 49 (2005) 4210-4219
2. Denis O., Deplano A., Nonhoff C., Hallin M., De Ryck R., Vanhoof R., et al. In vitro activities of ceftobiprole, tigecycline, daptomycin, and 19 other antimicrobials against methicillin-resistant Staphylococcus aureus strains from a national survey of Belgian hospitals. Antimicrob Agents Chemother 50 (2006) 2680-2685
3. van Eiff C., Friedrich A.W., Becker K., and Peters G. Comparative in vitro activity of ceftobiprole against staphylococci displaying normal and small-colony variant phenotypes. Antimicrob Agents Chemother 49 (2005) 4372-4374
4. Hebeisen P., Heinze-Krauss I., Angehrn P., Hohl P., Page M.G., and Then R.L. In vitro and in vivo properties of Ro 63-9141, a novel broad-spectrum cephalosporin with activity against methicillin-resistant staphylococci. Antimicrob Agents Chemother 45 (2001) 825-836
5. Goldstein E.J.C., Citron D.M., Merriam C.V., Warrern Y.A., Tyrrell K.L., and Fernandez H.T. In vitro activity of ceftobiprole against aerobic and anaerobic strains isolated from diabetic foot infections. Antimicrob Agents Chemother 50 (2006) 3959-3962
6. Bannerman T.L. Staphylococcus, micrococcus, and other catalase-positive cocci that grow aerobically. In: Murray P., Baron E.J., Jorgensen J.H., Pfaller M.A., and Yolken R.H. (Eds). Manual of clinical microbiology. 8th ed. (2003), ASM Press, Washington, DC 384-404
7. Clinical and Laboratory Standards Institute. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically. 7th ed. Approved standard. Document M7-A7. Wayne, PA: CLSI; 2006.